Search clinical trials for: TauroLock-Hep100 (taurolidine 1.35%, citrate 4%, heparin 100 IU/mL)

Total 5 results

Princess Maxima Center for Pediatric Oncology
UMC Utrecht; Dutch Cancer Society

Recruiting

Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. (CATERPILLAR)

Central Line-associated Bloodstream Infection (CLABSI)

Netherlands
Palle Bekker Jeppesen
TauroPharm

Unknown

Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml.

Catheter-related Bloodstream Infection (CRBSI) Nos

Denmark
Imperial College Healthcare NHS Trust

Completed

Taurolidine in Haemodialysis Catheter Related Bacteraemia

Catheter-Related Infections | Renal Dialysis

United Kingdom
CorMedix
PPD; Davita Clinical Research; JMI Laboratories; Spectra Clinical Research; Frenova...

Completed

Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection

Kidney Failure, Chronic | Catheter-Related Infections

United States
University of Manitoba
Winnipeg Regional Health Authority; MED XL Inc

Completed

Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study

Bacteremia | Catheter Related Infection

Canada

3

Subscribe